chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day 1: Reactions started around 4:20pm on February 5th. It started with my right arm going completely numb, next was my cheekbone, down to my mouth/ tongue going numb, and then my left leg, under my knee down to my toes went numb. I was also lightheaded and dizzy. Reaction happed for 4 hours and then went away. Day 2: Right arm randomly got pins and needles feeling.
Information has been received from a registered pharmacist concerning a 75 year old male who on 24-SEP-2009 was vaccinated with a dose of ZOSTAVAX (Merck). On 24-SEP-2009 the patient experienced shortness of breath and was hospitalized. The patient's outcome is unknown. Additional information has been requested.
Headache, Fever, Diarrhea, NauseaVomiting, Migraine HA, Chills/Sweats Narrative:
Patient fainted immediately after vaccination.  I was in the vaccination room with her and caught her head before it hit anything and supported her so she didn't fall out of the chair.
Received Varivax 6/20/07 10am. Comes in today 6/21/07 9cm by 6x5 cm erythematous swollen "target lesion" (R) arm
PARTIAL EPILEPSY GUILLAIN BARRE SYNDROME HYPOXIA EPILEPSY, PARTIAL IDIOPATHIC W STATUS EPILEPTICUS
This spontaneous report as received from a nurse refers to a 15 year old patient of an unknown gender. On 30-JAN-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
1st day pt had itching and bodyaches, 2nd day pt had pruritis of the arm.
Before she took the vaccine she had a sore throat and she informed the pharmacist and they told her it was ok to take the vaccine. After that she has had a continuous and diarrhea. She went to urgent care and they dx her with pneumonia.
PATIENT REPORTED SWELLING IN THE TONGUE, ITCHING AND BURNING RASH.  WAS SEEN AT DOCTORS OFFICE 24 HOURS AFTER VACCINE AND PATIENT REPORTED BEING GIVEN BENADRYL AND EPINEPHRINE.
severe allergic reaction to mango fruit after receiving the vaccine; hives all over her body; severe itching; entire body turned hot; This is a spontaneous report from a contactable consumer. A female patient (reporter's mother) of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 14Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient developed a severe allergic reaction to mango fruit after receiving the vaccine. She has eaten mangos all her life. In fact she has mango products at home at all times. She had taken both doses of the Pfizer vaccine. She had a small piece of a mango several weeks ago on an unknown date in 2021 and developed hives all over her body, severe itching and entire body turned hot. nitially patient didn't realize the allergic reaction was due to the mango. On Saturday night 17Apr2021 she had a small piece of a Mango and immediately had a severe allergic reaction and that is when we realized she had developed an allergic reaction to the mango. She took 2 zyrtecs and her Symbicort inhaler to relive symptoms. Symptoms subsided after 4 hours. Reporter strongly believe the allergy to mangos was a newly developed allergy associated with the vaccine as mango has been a staple in our diet and never experienced any issues before. Adverse event resulted in: [Life threatening illness (immediate risk of death from the event)]. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered on an unknown date in Apr2021. Information on the lot/batch number has been requested.
From initial information received on 1/24/05 from a healthcare professional regarding an adverse event occurring, it was reported that a 47 year old male patient received a dose of FLUZONE, lot number U1579AA, administered IM in the left deltoid on 1/21/05. Twelve hours later, the patient developed generalized itching and hives as well as chest tightness and shortness of breath. The patient treated himself with Benadryl and went to the emergency room. His pulse oximetry in the emergency room was 89%. He was treated with steroids and discharged home. Per the reporter, the patient received influenza vaccine annually with no reactions reported. Reportedly, the patient recovered from these events. (OMIC)
I had an asthma attack about 2 hours after the injection of PNEUMOVAX 23 Syringe at Pharmacy and the about 11pm and number 10 pain in the site of the injection I felt the pain going to the bone in my arm, deep pain. I could not move my arm not even put it up. The pain continued and I went to Dr the next day in the afternoon, he said take Tylenol 500mg every 6 hours also take Medrol pack for asthma, and I also  massage  my arm with menthol, I could not sleep, I woke up constantly because of the pain. I had some fever three days after and these symptoms continued for 7 days .
Case number PHEH2015US001456, is an initial spontaneous report from a consumer (also patient) received on 16 Jan 2015. This report refers to a 47-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. Vaccination history included administration of seasonal influenza vaccine (manufacturer unknown, batch number: not reported) in 1999 and experienced Guillain-Barre syndrome (see case: PHHY2015US006721). She was vaccinated with FLUCELVAX (batch number: not reported) intramuscularly on 02 Dec 2014. On 03 Dec 2014, the patient experienced paralysis from down the waist and in her arms. She was sent to the emergency room and the patient was hospitalized for six days. In the hospital, the patient was treated with intravenous immunoglobulin (IVIG) for Guillain-Barre syndrome (GBS). The patient still had numbness down the shins and was undergoing physical therapy. The symptoms of the GBS improved. Causality was not reported.
Chest tightness after second dose 40-45 minutes afterwards. No wheezing. Experienced Shortness of breath upon activity. Difficulty exhaling. O2 level was 96%. Took mucus, no relief. Multiple inhalations of Pro-Air, no relief. Took Albuterol nebulizer treatment, no relief. Took children?s  Benadryl approximately 4:30 PM and experienced immediate relief in 20 minutes.  Took more Benadryl proper to bedtime. Woke up next AM  and felt  like I felt prior to the vaccine.
Approximately 2 1/2 weeks after the vaccination, the patient became short of breath. Was evaluated at hospital ER and found to have suffered bilateral pulmonary emboli.
Became very tired, lost weight, then when we checked her Blood sugar was 428. 8/12/08-records received for DOS 8/31-9/1/07-DX:New onset diabetes. Began losing weight at end of school year from 182 to 115. Over the summer increasing thirst, polyphagia, polyuria with nocturia and increased fatigue. Began monitoring with insulin coverage as an outpatient but became hyperglycemic with sugars 401-500.   1/25/2010 Follow up: She has type 1 diabetes. She is insulin dependent and also takes Metformin twice a day because she is insulin resistant. She had none of the symptoms before the shot.
Pt reports generalized polyarthralgia, fatigue and malaise onset 1 week after J&J vaccine. Pt feels like these symptoms are directly related to his post-vaccine status and he reports the symptoms are more severe than he has felt in the past with any pseudogout flare.
Took third dose of Vivotif 24 hours late; Spontaneous report received on 24FEB2020.  A physician reported that a female consumer "took third dose of Vivotif 24 hours late" (PT: Inappropriate schedule of product administration). She was receiving Vivotif for immunisation. The consumer took the first two doses of Vivotif as per schedule but took the third dose 24 hours late. Action taken with Vivotif with respect to the reported event was not applicable. The outcome of the reported event was unknown.  Company Comment: A consumer took her third dose of Vivotif 24 hours late (Inappropriate schedule of product administration). Vivotif should be take every other day. Considering the nature of the event, the causality of Inappropriate schedule of product administration is assessed as not applicable to Vivotif.; Sender's Comments: A consumer took her third dose of Vivotif 24 hours late (Inappropriate schedule of product administration). Vivotif should be take every other day. Considering the nature of the event, the causality of Inappropriate schedule of product administration is assessed as not applicable to Vivotif.
felt cold; achiness; This case was reported by a consumer via call center representative and described the occurrence of feeling cold in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd July 2019, the patient received the 1st dose of Shingrix (intramuscular). On 23rd July 2019, less than a day after receiving Shingrix, the patient experienced feeling cold and pain. On 23rd August 2019, the outcome of the feeling cold and pain were recovered/resolved.   It was unknown if the reporter considered the feeling cold and pain to be related to Shingrix.  Additional case details were reported as follows: This case was reported by the patient's husband. The patient received vaccine in left arm. The reporter consented to follow up. This case had been linked to the case US2019171931, reported by same reporter.
A nurse reported the occurrence of a 52 year old female who did not respond to a series of hepatitis B recombinant (Engerix-B) for prophylaxis.  The subject had no relevant medical history or concurrent medications specified.  The subject had a current unspecified condition, which required dialysis.  On an unspecified date, the subject completed a four injection series of hepatitis B vaccine recombinant (Engerix-B).  On 01/09/03, an unspecified titer was drawn which resulted in a negative result.  Comment: This report has been linked to report A0392069A due to the same reporter.
who are fully vaccinated who tested positive; who are fully vaccinated who tested positive; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 18May2021 (Batch/Lot Number: EW0178) as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 via an unspecified route of administration, administered in Arm Right on 27Apr2021 (Batch/Lot Number: EW0167) as for covid-19 immunization. Any other vaccinations within four weeks prior to the first administration date of the suspect vaccine reported as none. AEs following prior vaccinations reported as none. On 18Aug2021, the patient experienced who are fully vaccinated who tested positive (medically significant). Reporter states her husband is fully vaccinated. He had the second dose since tested positive for the virus. They have 4 other friends who are fully vaccinated who tested positive. The patient did not visit emergency room or physician office for AEs. The patient underwent lab tests and procedures which included sars-cov-2 test as positive on an unspecified date in 2021. The outcome of events was not recovered.   Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101095688 same reporter/drug/AE, different patients.
Patient had a minor panic attack 15 minutes after vaccine was given. Paramedics were called, patient was evaluated by paramedics and was stable and release home.
92-year-old female, presented from home (lives with her son) after being found by the son slumped over to the right on the toilet.  She is hypothyroid after treatment for thyroid cancer.  She apparently aspirated after an emesis and she has virtually no cough reflex with suctioning.  Her COVID test was positive, but she was at least 10 days post positive and is asymptomatic.  Her white blood count is elevated.  She has a history of hypertension, hyperlipidemia, CVA.  She is nonresponsive. She started to move whenever involves arms a bit. She has some bradycardia. She had 1 brief episode of atrial fibrillation again and have returned to normal sinus rhythm.  Her final cultures were negative and the patient was discharged on 08/30/2022 to subacute rehab at a Skilled Nursing Facility and Rehab Facility.
Patient returned to pharmacy on 8/11/11 & complained of localized reaction to shot. She said her arm at injection site is red, painful, hot & itchy. I counselled to apply a cold compress & to continue ADVIL if needed & to let her MD aware.
Patient with febrile seizure, seen in ER at 8:54 PM.  Mom reported child staring, very sleepy.  Staring lasted 5-7 min and then unresponsive followed by vomiting and a gradual return to baseline per ER report.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 21-DEC-2015 the patient was vaccinated with a dose of improperly stored (unspecified temperature excursions) ZOSTAVAX (Lot# reported as L027327, expiration date 21-OCT-2016, dose and route unknown). No adverse symptoms was reported. Lot number L02737 is an invalid lot number for ZOSTAVAX. Additional information has been requested.
woke ~2am with severe n/v/d - + generalized abd pain; no brbpr or melena; no fever
Apnea, limp, weak, dec response, projectile vomiting, t37.5C, TC to mom pt is fine, sx lasted 1 day;
No Adverse Event; They gave her the incorrect shot, that they accidentally gave her the standard child's dose./received an incorrect vaccine; This spontaneous case was reported by a patient family member or friend and describes the occurrence of WRONG PRODUCT ADMINISTERED (They gave her the incorrect shot, that they accidentally gave her the standard child's dose./received an incorrect vaccine) and NO ADVERSE EVENT (No Adverse Event) in a 6-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (They gave her the incorrect shot, that they accidentally gave her the standard child's dose./received an incorrect vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, WRONG PRODUCT ADMINISTERED (They gave her the incorrect shot, that they accidentally gave her the standard child's dose./received an incorrect vaccine) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. No concomitant medication was provided by the reporter.  It was reported that patient was taken to the pharmacy to get the updated Moderna Bivalent booster. They gave patient the incorrect shot, that they accidentally gave patient the standard child's dose.  No treatment medication was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 24-Oct-2022: Live follow up received included significant information suspect product start date was added.
Patient reported red splotch on injection arm. Appeared 10 days after vaccine. Self treated with anithistamines. Resolved in 2 days.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 68-year-old male patient who received SHINGRIX (batch number ZN22Z, expiry date 28th February 2021) for prophylaxis. On 30th August 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX vaccine on left deltoid.
I got the shot in May I tested positive in Sept after I had a COVID-19 home test and have symptoms for three days, I had cough and lasted for three weeks. The first day I had runny nose, headaches, cough, never had a fever. I went to the doctor after I tested positive and they did another test and it was positive also, they gave me a prescription.
I not have a menstrual cycle from 10/31/21 through 1/31/2022. I have always had a regular menstrual cycle my entire life. I am not pregnant nor was I trying to get pregnant either.
Shortness of breath with wheezing.  Suspect laryngospan.  Urticarial lesions on face, trunk and extremities.  Required epinephrine x2.
Approx 12-15 minutes after vaccine was administered, pt said she "didn't feel good". When asked how she felt, she started shaking, saying her vision was blurry, she felt nauseous. A few minutes later she said it was getting difficult to breathe. An ambulance was called.
States she developed headache (top area head) light-headedness, nausea, arm injection site red warm and swollen x 3 days. Pt reports allergies to pcn and amoxicillin but is "sensitive" to all medications, especially antibiotics. States previous physician always called her in 24 hrs after starting any new medications to make sure she was not having any reactions. Pt reports has hypertension, restless leg syndrome and hypothyroidism. States this was first flu vaccine she received since about 20 years ago. States used to react similarly to vaccine in past. States was born  with part of 2 vertebras missing but has had surgery to correct this. Pt instructed to come to health dept to see nurse practitioner for complaint but she refuses. States feels better now.
Patient felt sudden onset of flushing with palpitations and chest tightness. She also reported shortness of breath and dizziness.
I received both the seasonal flu nasal mist vaccine and the H1N1 vaccine by injection at the same visit because it was offered to me for free.  Went home, had dinner, went to sleep, when I got up at %AM to go to the bathroom, my vision was blurry, hazy, had confusion and dizziness.  Also my neck felt stiff and my left arm where I received the injection was numb.  I almost fell down due to the dizziness but didn't.  Next day I noticed memory problems also.  I called the clinic where I received the injections, they didn't seem to care and told me to call my medical doctor.  I was hoping this would go away, I gave it two weeks, hadn't gone away, called me medical doctor.  She never responded to me and still hasn't.  On Saturday Dec. 19, I had another dizziness spell, and fell down and hit my head.  I went to the ER.  They did numerous tests.  I still have all the symptoms and we are nearing the end of December and the night vision and light sensitivity seems worse.
84 y/o male, PMHx of CKD stage 3, CAD, DM, HTN, Stroke, kidney stone, admitted for weakness, borderline hypoxia, and urinary retention on 12/7/21. Urinary retention treated with Flomax. Pt developed likely aspiration pneumonitis during hospital stay which was treated with IV abx. Pt was discharged to a skilled nursing facility on 12/16/21.
doses given after temperature excursion; 20 minute excursion in the freezer; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (20 minute excursion in the freezer) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Nov-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (20 minute excursion in the freezer). On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion). On 28-Nov-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (20 minute excursion in the freezer) had resolved. At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided. The facility had a 20 minute excursion in the freezer where the Moderna COVID 19 vials were stored in.
Vaccine was stored incorrectly; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine was stored incorrectly) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored incorrectly). On 01-Mar-2021, PRODUCT STORAGE ERROR (Vaccine was stored incorrectly) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD21-041703, MOD21-041814 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2021: Follow-up received include no new information.; Reporter's Comments: This report refers to a case of product storage error  for mRNA-1273, lot # 025A21A  with no associated AEs.; Sender's Comments:  MOD21-041703:crosslinked MOD21-041814:crosslinked
Rash of blister-like red spots, like chicken pox, very itchy. Began five days after vaccination as one spot on left wrist  and over three days spread to both arms, back, neck, chest. Spots stopped itching after five days, and existing spots started to look less ?angry,? though more spots appeared on legs. Decided not to seek medical care. Rash had pretty fully abated after 10 days.